MLAB - メサ・ラボラトリ―ズ （Mesa Laboratories Inc.） メサ・ラボラトリ―ズMLABのチャート
MLABの企業情報
| symbol | MLAB |
|---|---|
| 会社名 | Mesa Laboratories Inc. （メサ・ラボラトリ―ズ） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Industrial Machinery/Components |
| 業種 | 産業機械_装置 IT・通信（IT_Communications） |
| 概要 | 事業概要 メサ･ラボラトリーズ(Mesa Laboratories Inc.)は品質管理製品およびサービスの提供に従事する。同社は4つの事業を通じて運営する。インスツルメンツ事業は品質管理機器および使い捨て製品を設計、製造、販売する。生物学的測定器事業は試験サービスを提供し、生物学的測定器の製造およびマーケティングを行い、滅菌プロセスの有効性を評価するために使用される化学測定器の販売を行う。継続的監視事業は各種環境パラメータを監視するために使用されるシステムを設計、開発、販売する。コールド・チェーン事業はコールドチェーン製品のパラメータを監視する。同社のブランドには、「DataTrace」、「DialyGuard」、「DryCal」、「Torqo」、「SureTorque」、「BGI」、「Mesa」、「PCD」、「Apex」、「CheckPoint」、「Mesa」、「TempTrust」が含まれる。 メサ・ラボラトリ―ズは、米国の電子計測機器メ―カ―。工業分野や血液透析で利用する電子計測機器を設計、製造、販売する。事業は、器具、生物学的指標、連続モニタリングの3部門で構成。器具部門は、品質管理機器と使い捨て製品を展開。主要製品は、パイプライン流量計、血液透析器や配分器の測定装置、温度センサ―、デ―タ記録計など。 Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help its customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. |
| 本社所在地 | 12100 West Sixth Avenue Lakewood CO 80228 USA |
| 代表者氏名 | John J. Sullivan ジョン・サリバン |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 303-987-8000 |
| 設立年月日 | 30011 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 366人 |
| url | www.mesalabs.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mlab |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 28.43200 |
| 終値（lastsale） | 178.2 |
| 時価総額（marketcap） | 686208105 |
| 時価総額 | 時価総額（百万ドル） 698.91560 |
| 売上高 | 売上高（百万ドル） 98.64800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 730.92760 |
| 当期純利益 | 当期純利益（百万ドル） -0.30800 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 30 June 2018 Mesa Laboratories Inc. revenues increased 11% to $25.1M. Net income increased from $1.5M to $4.2M. Revenues reflect Sterilization and Disinfection Control segment increase of 11% to $11.3M Cold Chain Packaging segment increase of 90% to $1.8M United States segment increase of 19% to $15.5M. Net income benefited from Selling decrease of 29% to $1.9M (expense). |
MLABのテクニカル分析
MLABのニュース
Mesa Laboratories: Q4 Earnings Insights 2022/05/31 13:42:51 Benzinga
Mesa Laboratories (NASDAQ: MLAB ) reported its Q4 earnings results on Tuesday, May 31, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Mesa Laboratories beat estimated earnings by 362.5%, reporting an EPS of $2.22 versus … Full story available on Benzinga.com
Mesa Laboratories GAAP EPS of -$0.34 misses by $0.82, revenue of $58.88M beats by $2.58M 2022/05/31 12:12:31 Seeking Alpha
Mesa Laboratories press release (MLAB): Q4 GAAP EPS of -$0.34 misses by $0.82.Revenue of $58.88M (+55.1% Y/Y) beats by $2.58M.
Mesa Laboratories goes ex-dividend tomorrow 2022/05/26 15:23:23 Seeking Alpha
Mesa Laboratories (MLAB) had declared $0.16/share quarterly dividend, in line with previous. Payable June 15; for shareholders of record May 31; ex-div May 27.
Mesa Laboratories Non-GAAP EPS of $1.36 beats by $0.04, revenue of $54.69M beats by $10.22M 2022/02/03 14:12:41 Seeking Alpha
Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04.Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M.
Mesa Laboratories, Inc. Shares Close in on 52-Week High - Market Mover 2022/01/04 13:26:57 Kwhen Finance
Mesa Laboratories, Inc. (MLAB) shares closed today at 1.3% below its 52 week high of $333.42, giving the company a market cap of $1B. The stock is currently up 0.3% year-to-date, up 15.1% over the past 12 months, and up 170.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 71.7% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -49.8% The company's stock price performance over the past 12 months lags the peer average by -49.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -17683.1% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Mesa Laboratories Non-GAAP EPS of $1.36 beats by $0.04, revenue of $54.69M beats by $10.22M 2022/02/03 14:12:41 Seeking Alpha
Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04.Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M.
Mesa Laboratories, Inc. Shares Close in on 52-Week High - Market Mover 2022/01/04 13:26:57 Kwhen Finance
Mesa Laboratories, Inc. (MLAB) shares closed today at 1.3% below its 52 week high of $333.42, giving the company a market cap of $1B. The stock is currently up 0.3% year-to-date, up 15.1% over the past 12 months, and up 170.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 71.7% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -49.8% The company's stock price performance over the past 12 months lags the peer average by -49.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -17683.1% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Mesa Laboratories, Inc. Shares Near 52-Week High - Market Mover 2021/12/26 04:53:31 Kwhen Finance
Mesa Laboratories, Inc. (MLAB) shares closed today at 0.9% below its 52 week high of $331.90, giving the company a market cap of $1B. The stock is currently up 15.0% year-to-date, up 15.7% over the past 12 months, and up 161.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 43.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -46.6% The company's stock price performance over the past 12 months lags the peer average by -49.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -18471.3% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Mesa Laboratories, Inc. Shares Close in on 52-Week High - Market Mover 2021/12/23 13:59:00 Kwhen Finance
Mesa Laboratories, Inc. (MLAB) shares closed today at 1.2% below its 52 week high of $331.90, giving the company a market cap of $1B. The stock is currently up 14.7% year-to-date, up 15.2% over the past 12 months, and up 161.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 56.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -44.2% The company's stock price performance over the past 12 months lags the peer average by -47.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -17222.7% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Mesa Laboratories (NASDAQ:MLAB) Reaches New 12-Month High at $331.90 2021/12/18 11:54:42 Dakota Financial News
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) hit a new 52-week high on Thursday . The company traded as high as $331.90 and last traded at $318.58, with a volume of 24663 shares trading hands. The stock had previously closed at $325.55. Several research firms have commented on MLAB. TheStreet upgraded shares of Mesa Laboratories from []
Mesa Laboratories (NASDAQ:MLAB) Upgraded by TheStreet to B- 2021/11/08 06:18:44 Dakota Financial News
TheStreet upgraded shares of Mesa Laboratories (NASDAQ:MLAB) from a c rating to a b- rating in a report published on Thursday, TheStreetRatingsTable reports. Separately, Zacks Investment Research raised Mesa Laboratories from a hold rating to a strong-buy rating and set a $344.00 price target for the company in a research report on Wednesday, October 6th. []
Mesa Laboratories (NASDAQ:MLAB) Upgraded at TheStreet 2021/11/07 06:04:45 Transcript Daily
TheStreet upgraded shares of Mesa Laboratories (NASDAQ:MLAB) from a c rating to a b- rating in a research report sent to investors on Thursday, TheStreetRatingsTable reports. Separately, Zacks Investment Research raised shares of Mesa Laboratories from a hold rating to a strong-buy rating and set a $344.00 price target on the stock in a research []
Mesa Labs Announces Second Quarter Results 2021/11/04 12:00:00 Intrado Digital Media
LAKEWOOD, Colo., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its second fiscal quarter (2Q22) and six months ended September 30, 2021.
Mesa Laboratories, Inc. (NASDAQ:MLAB) Expected to Post Earnings of $1.29 Per Share 2021/10/30 03:16:41 Transcript Daily
Brokerages expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to report earnings of $1.29 per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Mesa Laboratories earnings. The lowest EPS estimate is $0.96 and the highest is $1.65. Mesa Laboratories posted earnings of $1.91 per share in the same quarter last year, []